ANN ARBOR STAGE II B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE II B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE II B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE II B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy joins forces with chemo in fight against Fast-Growing lymphoma
Disease control OngoingThis study is testing whether adding the immunotherapy drug nivolumab to a standard chemotherapy regimen (called DA-REPOCH) works better for treating aggressive B-cell non-Hodgkin's lymphoma. The goal is to see if this combination helps patients live longer without their cancer g…
Matched conditions: ANN ARBOR STAGE II B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: David Bond, MD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Gentler radiation zaps eye lymphoma with fewer side effects
Disease control OngoingThis study is testing whether a very low dose of radiation aimed at the eye socket can effectively control slow-growing B-cell lymphomas that involve the eye area. It aims to see if this lower dose can work as well as standard treatments while causing fewer side effects. The tria…
Matched conditions: ANN ARBOR STAGE II B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC